Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyman Regulatory News (TYMN)

Share Price Information for Tyman (TYMN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 382.50
Bid: 382.50
Ask: 383.00
Change: 2.50 (0.66%)
Spread: 0.50 (0.131%)
Open: 375.00
High: 384.00
Low: 375.00
Prev. Close: 380.00
TYMN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 and Dividend Update

3 Apr 2020 07:00

RNS Number : 6614I
Tyman PLC
03 April 2020
 

TYMAN PLC

COVID-19 and Dividend Update

Tyman plc ("Tyman" or the "Group"), a leading international supplier of engineered components and access solutions to the construction industry, provides an update on the impact of the Covid-19 pandemic on its business and the actions being taken to manage this situation.

Business impact

Since the announcement of our 2019 preliminary results on 5th March 2020, the crisis situation with the COVID-19 pandemic has changed significantly.

The Group's priority continues to be ensuring the health and safety of our employees, their families and our communities, especially at the current time. We have acted quickly to implement enhanced hygiene and social distancing measures across the Group, including moving employees to remote home working where possible.

The Group's 2020 trading performance was in line with our expectations until the middle of March. Since then, trading has progressively been impacted as increasingly stringent lockdowns have taken effect in our markets. We have responded accordingly, temporarily closing our facilities in the UK and Italy. Our sites in North America are currently operating but with a marked reduction in order intake now being seen. The situation however remains fluid and is being closely monitored and actively managed.

Balance sheet and liquidity

The Group enters this period of volatility and uncertainty with a robust balance sheet. At 31st December 2019, net debt excluding leases was £163m and net debt to EBITDA ratio on a covenant basis was 1.7x (2018: 2.3x) compared with the covenant limit of 3.0x. The Group has a cash balance of £121m as at 31st March 2020, having recently drawn down against our revolving credit facility of £240 million, with £4m remaining undrawn. The earliest maturing debt is a $55m tranche of our US Private Placement that is due for repayment in November 2021.

Focus on cash preservation and withdrawal of final dividend

The Group has put in place a broad range of measures with focus on optimisation of cash flow via cost savings, working capital reduction and tight management of capital expenditure. The Group is also making use of government employee programmes, tax relief and other measures as they become available in all our geographies. For example, in the UK, 80% of the workforce are currently furloughed.

As part of the leadership's response, the Board and senior management have elected to take a base salary reduction of 25% and 20% respectively, effective from 1st April 2020. In addition, the Group has decided to cancel the 2020 management bonus scheme.

Given the considerable level of uncertainty, the Board has taken the decision to cancel the final dividend payment of 8.35p per ordinary share that was proposed with the 2019 results announcement on 5 March 2020. The cash impact of this decision is £16m in H1 2020. Future dividend decisions will be made as and when conditions normalise.

We have assessed the impact on both profitability and cash flow of various potential scenarios of different durations and severity. We will continue to monitor the evolution of the crisis and remain flexible to adjust plans as necessary. With the actions being taken, we are confident that we are well-placed to withstand a prolonged period of reduced trading.

Outlook

Given the unprecedented levels of uncertainty at this time, previous guidance on the Group's future performance is being withdrawn. The Group will provide further updates when there is greater clarity on the impact of COVID-19 on the trading environment. This will include an update at the AGM, which is planned to proceed on 20th May 2020 while adhering to government movement restrictions.

Jo Hallas, CEO, commented:

"Since the start of the crisis, we have taken decisive action to protect our employees, reduce costs and preserve cash. These actions combined with our headroom and operational flexibility give us confidence that we can manage through the uncertainties ahead. Tyman's inherent strengths including market-leading brands and deep customer relationships position the Group to emerge well-placed for future growth once the current crisis recedes."

 

3 April 2020

 

Enquiries

Tyman plc

020 7976 8000

Jo Hallas - Chief Executive Officer

www.tymanplc.com

Jason Ashton - Chief Financial Officer

MHP Communications

020 3128 8100

Reg Hoare / Rachel Mann / Ailsa Prestige

Notes to editors

Tyman (TYMN: LSE) is a leading international supplier of engineered fenestration components and access solutions to the construction industry. The company designs and manufactures products that enhance the comfort, sustainability, security, safety and aesthetics of residential homes and commercial buildings. Tyman's portfolio of leading brands serve their markets through three divisions: North America (AmesburyTruth), UK and Ireland (ERA) and International (SchlegelGiesse). Headquartered in London, the Group employs approximately 3,900 people with facilities in 18 countries worldwide. Further information is available at www.tymanplc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFZGGDLZGGGZM
Date   Source Headline
4th Mar 202111:36 amRNSDividend Declaration
4th Mar 20217:00 amRNSFinal Results
30th Dec 20209:45 amRNSDirector/PDMR Shareholding - Replacement
24th Dec 20209:45 amRNSDirector/PDMR Shareholding
10th Dec 20202:56 pmRNSHolding(s) in Company
8th Dec 20207:00 amRNSTrading Statement
2nd Nov 20206:12 pmRNSTotal Voting Rights
29th Oct 20206:04 pmRNSHolding(s) in Company
26th Oct 20204:05 pmRNSHolding(s) in Company
7th Oct 20207:00 amRNSTrading and COVID-19 Update
5th Oct 20205:45 pmRNSHolding(s) in Company
1st Oct 20204:00 pmRNSDirector/PDMR Shareholding
1st Oct 20204:00 pmRNSDirector/PDMR Shareholding
17th Sep 20207:00 amRNSDirectorate Changes
28th Aug 20204:20 pmRNSHolding(s) in Company
28th Aug 20204:20 pmRNSHolding(s) in Company
6th Aug 20207:00 amRNSDirector/PDMR Shareholding
4th Aug 20207:00 amRNSHolding(s) in Company
4th Aug 20207:00 amRNSHolding(s) in Company
29th Jul 20205:00 pmRNSHolding(s) in Company
29th Jul 20205:00 pmRNSHolding(s) in Company
28th Jul 20207:00 amRNSHalf-year Report
27th Jul 20202:03 pmRNSHolding(s) in Company
27th Jul 20202:02 pmRNSHolding(s) in Company
3rd Jun 20207:00 amRNSHolding(s) in Company
21st May 20203:30 pmRNSHolding(s) in Company
20th May 202010:40 amRNSResult of AGM
20th May 20207:00 amRNSAnnual General Meeting Trading and COVID-19 Update
4th May 20204:14 pmRNSDirector/PDMR Shareholding
17th Apr 20202:33 pmRNSHolding(s) in Company
8th Apr 20207:00 amRNSNotice of AGM
3rd Apr 20203:07 pmRNSDirector/PDMR Shareholding
3rd Apr 20207:00 amRNSCOVID-19 and Dividend Update
26th Mar 20207:00 amRNSDirector/PDMR Shareholding
20th Mar 20204:31 pmRNSDirector/PDMR Shareholding
17th Mar 20204:37 pmRNSPrice Monitoring Extension
10th Mar 202011:46 amRNSHolding(s) in Company
6th Mar 20205:28 pmRNSHolding(s) in Company
5th Mar 202012:23 pmRNSDirector/PDMR Shareholding
5th Mar 20207:00 amRNSFinal Results
23rd Jan 202011:49 amRNSHolding(s) in Company
12th Dec 20197:04 amRNSDirectorate Change
18th Nov 20193:34 pmRNSHolding(s) in Company
6th Nov 20197:00 amRNSTrading Statement
3rd Oct 201911:08 amRNSHolding(s) in Company
3rd Oct 201911:07 amRNSHolding(s) in Company
2nd Oct 201911:17 amRNSDirector/PDMR Shareholding
30th Sep 20193:29 pmRNSDirector/PDMR Shareholding
30th Sep 20193:27 pmRNSDirector/PDMR Shareholding
29th Aug 20197:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.